Activity of Methylated Forms of Selenium in Cancer Prevention

Cancer Research

Volumn 50, Issue 4, 1990, Pages 1206-1211

  Ip, Clement ^a   Ganther, Howard E ^b  

^a Rosweli Park Memorial Institute ^*  (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARSENIC TRIOXIDE; DIMETHYLBENZ[A]ANTHRACENE; EBSELEN; SELENOBETAINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CARCINOGENESIS; CANCER INHIBITION; METHYLATION; NONHUMAN; PRIORITY JOURNAL; RAT;

9,10-DIMETHYL-1,2-BENZANTHRACENE; ANIMAL; ARSENIC; AZOLES; BETAINE; DRUG SYNERGISM; FEMALE; MAMMARY NEOPLASMS, EXPERIMENTAL; RATS; RATS, INBRED STRAINS; SELENIOUS ACID; SELENIUM; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0025064250     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Ip, and Medina, D. Current concept of selenium and mammary tumorigenesis. In: D. Medina, W. Kidwell, G. Heppner, and E. P. Anderson (eds.), Cellular and Molecular Biology of Breast Cancer, pp. 479–494. New York: Plenum Publishing Corp., 1987.
2. Thompson, H. J., Meeker, L. D., and Kokoska, S. Effect of an inorganic and organic form of dietary selenium on the promotional stage of mammary carcinogenesis in the rat. Cancer Res., 44: 2803–2806, 1984.
3. Ip, C., and Hayes, C. Tissue selenium levels in selenium-supplemented rats and their relevance in mammary cancer protection. Carcinogenesis (Lond.), 70:921–925, 1989.
4. Greeder, G. A., and Milner, J. A. Factors influencing the inhibitory effect of selenium on mice inoculated with Ehrlich ascites tumor cells. Science (Wash. DC), 209: 825–827, 1980.
5. Milner, J. A., and Hsu, C. Y. Inhibitory effects of selenium on the growth of LI210 leukemic cells. Cancer Res., 41:1652–1656, 1981.
6. Tanaka, T., Reddy, B. S., and El-Bayoumy, K. Inhibition by dietary organoselenium, p-methoxybenzeneselenol, of hepatocarcinogenesis induced by azoxymethane in rats. Jpn. J. Cancer Res., 76:462–467, 1985.
7. Reddy, B. S., Tanaka, T., and El-Bayoumy, K. Inhibitory effect of dietary p-methoxybenzeneselenol on azoxymethane-induced colon and kidney carcinogenesis in female F344 rats. J. Natl. Cancer Inst., 74:1325–1328, 1985.
8. El-Bayoumy, K. Effects of organoselenium compounds on induction of mouse forestomach tumors by benzo(a)pyrene. Cancer Res., 45: 3631–3635,1985.
9. Reddy, B. S., Sugie, S., Maruyama, H., El-Bayoumy, K., and Marra, P. Chemoprevention of colon carcinogenesis by dietary organoselenium, benzylselenocyanate, in F344 rats. Cancer Res., 47: 5901–5904, 1987.
10. Nayini, J., El-Bayoumy, K., Sugie, S., Cohen, L. A., and Reddy, B. S. Chemoprevention of experimental mammary carcinogenesis by the synthetic organoselenium compound, benzylselenocyanate, in rats. Carcinogenesis (Lond.), 70:509–512, 1989.
11. Ip, C. Differential effect of dietary methionine on the biopotency of selenomethionine and selenite in cancer chemoprevention. J. Natl. Cancer Inst., 80: 258–262, 1988.
12. Ip, C., and Ganther, H. Efficacy of trimethylselenonium versus selenite in cancer chemoprevention and its modulation by arsenite. Carcinogenesis (Lond.), 9: 1481–1484, 1988.
13. Ip, C. Prophylaxis of mammary neoplasia by selenium supplementation in the initiation and promotion phases of chemical carcinogenesis. Cancer Res., 47:4386–4390,1981.
14. Ganther, H. E. Pathways of selenium metabolism including respiratory excretory products. J. Am. Coll. Toxicol., 5: 1–5, 1986.
15. Sunde, R. A. The biochemistry of selenoproteins. J. Am. Oil Chemists Soc., 61:1891–1900, 1984.
16. Sunde, R. A., and Evenson, J. K. Serine incorporation into the selenocysteine moiety of glutathione peroxidase. J. Biol. Chem., 262:933–937, 1987.
17. Foster, S. J., Kraus, R. J., and Ganther, H. E. Formation of dimethylselenide and trimethylselenonium from selenobetaine in the rat. Arch. Biochem. Biophys., 247:12–19, 1986.
18. Parnham, M. J., and Graf, E. Seleno-organic compounds and the therapy of hydroperoxide-linked pathological conditions. Biochem. Pharmacol., 36: 3095–3102, 1987.
19. Muller, A., Gabriel, H., Sies, H., Terlinden, R., Fischer, H., and Romer, A. A novel biologically active seleno-organic compound-VII. Biotransformation of Ebselen in perfused rat liver. Biochem. Pharmacol., 37: 1103–1109, 1988.
20. Fischer, H., Terlinden, R., Lohr, J. P., and Romer, A. A novel biologically active selenoorganic compound. VIII. Biotransformation of ebselen. Xeno-biotica, 18:1347–1359, 1988.
21. Wendel, A., Fausel, M., Safayhi, H., Tiegs, G., and Otter, R. A novel biologically active seleno-organic compound-II. Activity of PZ51 in relation to glutathione peroxidase. Biochem. Pharmacol., 33:3241–3245, 1984.
22. Report of the American Institute of Nutrition Ad Hoc Committee on Standards for Nutritional Studies. J. Nutr., 107: 1340–1348, 1977.
23. Ip, C. Ability of dietary fat to overcome the resistance of mature female rats to 7,12-dimethylbenz(a)anthracene-induced mammary tumorigenesis. Cancer Res., 40: 2785–2789, 1980.
24. Horvath, P. M., and Ip, C. Synergistic effect of vitamin E and selenium in the chemoprevention of mammary carcinogenesis in rats. Cancer Res., 43: 5335–5341, 1983.
25. Foster, S. F., Kraus, R. J., and Ganther, H. E. Generation of [75Seldimethyl-selenide and the synthesis of [75Se]dimethyIselenonium compounds. J. Labelled Compd. Radiopharm., 22: 301–311, 1985.
26. Olson, O. E., Palmer, I. S., and Carey, E. E. Modification of the official fluorometric method for selenium in plants. J. Assoc. Offic. Anal. Chem., 58: 117–121, 1975.
27. Paglia, D. E., and Valentine, W. N. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J. Lab. Clin. Med., 70:158–169, 1967.
28. Morrison, D. G., Dishart, M. K., and Medina, D. Intracellular 58-kd selenoprotein levels correlate with inhibition of DNA synthesis in mammary epithelial cells. Carcinogenesis (Lond.), 9: 1801–1810, 1988.
29. Hsieh, H. S., and Ganther, H. E. Biosynthesis of dimethyl selenide from sodium selenite in rat liver and kidney cell-free systems. Biochim. Biophys. Acta, 497: 205–217, 1977.
30. Mozier, N. M., McConnell, K. P., and Hoffman, J. L. S-Adenosyl-L-methi-onine:thioether-5-methyltransferase, a new enzyme in sulfur and selenium metabolism. J. Biol. Chem., 263:4527–4531,1988.
31. Ching, W.-M. Occurrence of selenium-containing tRNAs in mouse leukemia cells. Proc. Natl. Acad. Sci. USA, 81: 3010–3013, 1984.
32. Palmer, I. S., Arnold, R. I., and Carlson, C. W. Toxicity of various selenium derivatives to chick embryos. Poultry Sci., 52: 1841–1846, 1973.
33. Kharasch, N., and Thyagarajan, B. S. Structural basis for biological activities of dimethyl sulfoxide. Ann. NY Acad. Sci., 411:391–402, 1983.
34. Ip, C. Factors influencing the anticarcinogenic efficacy of selenium in dimethylbenz(a)anthracene-induced mammary tumorigenesis in rats. Cancer Res., 47:2683–2686,1981.
35. Ip, C., and Daniel, F. B. Effects of selenium on 7,12-dimethylbenz-(a)anthracene-induced mammary carcinogenesis and DNA adduct formation. Cancer Res., 45:61–65, 1985.